Camblong Jurgi 4

4 · SOPHiA GENETICS SA · Filed Jul 7, 2026

AI-generated summary of this filing

Updated Jul 7, 2026

SOPHiA GENETICS (SOPH) Exec Chairman Jurgi Camblong Sells 22,486 Shares

What Happened

Jurgi Camblong, Executive Chairman and Director of SOPHiA GENETICS (SOPH), sold 22,486 shares in open-market transactions on July 6, 2026. The filing reports a weighted-average price of $5.25 per share for total proceeds of approximately $118,164. The sales were effected to satisfy tax withholding obligations related to restricted stock units that vested earlier in July.

Key Details

Transaction date: July 6, 2026
Report filed: July 7, 2026 (timely)
Shares sold: 22,486
Weighted-average price reported: $5.25; price range across multiple trades: $4.97–$5.43 (footnote offers breakdown on request)
Purpose/footnotes: Sold to satisfy tax withholding on RSU vestings (footnote F1); executed under a pre-established Rule 10b5-1(c) plan and were non-discretionary
Shares owned after transaction: Not disclosed in this summary filing

Context

These sales were tax-withholding transactions tied to RSU vesting and executed under a 10b5-1 plan, which generally indicates pre-planned, non-discretionary sales rather than opportunistic insider selling. For more granular price-per-trade details or current beneficial ownership, consult the full Form 4 (Accession 0001840706-26-000246).

Form 4

Period: 2026-07-06

DirectorExecutive Chairman

Transactions

Sale
Ordinary Shares
[F1][F2]
2026-07-06$5.25/sh−22,486$118,164→ 3,558,807 total

Footnotes (2)

[F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on July 2 and July 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
[F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.97 to $5.43, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Signature

/s/ Elimara Brunetto as Attorney-in- Fact for Jurgi Camblong|2026-07-07

1 file